MAPT and Alzheimer disease: AEP is active in acidic conditions within lysosomes, but lysosomal leakage results in translocation of AEP into the cytoplasm where it cleaves inhibitor 2 of protein phosphatase 2A (I2PP2A) that leads to increased tau hyperphosphorylation in AD (Basurto-Islas et al., 2018).